CHINARES PHARMA

03320

----

Current ValuationThe current P/E ratio is 6.02, below the reasonable range, cheaper than 95.48% of the time in the past 5 years, and the industry ranks 4/52, the industry Median 6.85.

6.02xP/E

Stock priceHK$4.59Earnings per shareHK$0.76

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

Industry median 6.85x

09182736

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

Industry median 6.85x

0x20x40x60x80x100x

P/E ratio
Name/Symbol
03320HKCHINARES PHARMA	6.02x	7.23%	HK$28.81B
01681HKCONSUN PHARMA	9.66x	20.92%	HK$13.07B
02186HKLUYE PHARMA	8.00x	47.27%	HK$6.41B
02877HKSHINEWAY PHARM	6.54x	16.89%	HK$6.06B
02633HKJACOBSON PHARMA	6.23x	1.99%	HK$1.88B
08049HKJILIN CHANGLONG	5.98x	--	HK$1.51B
02348HKDAWNRAYS PHARMA	5.31x	--	HK$1.42B
02161HKJBM HEALTHCARE	6.85x	6.78%	HK$1.38B
00239HKPAK FAH YEOW	7.83x	--	HK$774.43M
00950HKLEE'S PHARM	5.36x	--	HK$641.83M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.